HYPERCALCEMIA DUE TO PRIMARY HYPERPARATHYROIDISM IN A PATIENT WITH GRAVES' DISEASE

Yıl 2022, Cilt: 24 Sayı: 1, 192 - 196, 30.04.2022

Işılay Kalan Sarı Ramazan Coşar Şenay Arıkan Durmaz

https://doi.org/10.24938/kutfd.857414

Öz

Hyperthyroidism is a hypermetabolic condition associated with excessive production of thyroid hormones by the thyroid gland. Thyroid hormones play an important role in bone and calcium metabolism. Mild to moderate hypercalcemia due to hyperthyroidism has been reported in approximately one in five patients. Hypercalcemia due to hyperthyroidism is associated with decreased or subnormal parathyroid hormone levels. The co-occurrence of hyperthyroidism and primary hyperparathyroidism is rare. However, in patients with hyperthyroidism, it is necessary to evaluate the parathyroid glands if hypercalcemia persists after an euthyroid state is reached.

Here, we report the case of a 30-year-old man with hypercalcemia who had Graves' disease and primary hyperparathyroidism and was successfully treated with combined thyroid and parathyroid surgery.

Anahtar Kelimeler

hyperthyroidism, hyperparathyroidism, hypercalcemia, Graves

Bir Graves Hastasında Primer Hiperparatiroidiye Bağlı Hiperkalsemi

Öz

Hipertiroidizm, tiroid bezi tarafından aşırı tiroid hormonu üretimi ile olan ilişkili hipermetabolik bir durumdur. Tiroid hormonlarının kemik ve kalsiyum metabolizması üzerine önemli etkileri vardır. Yaklaşık beş hastadan birinde hipertiroidiye bağlı hafif ila orta derecede hiperkalsemi bildirilmiştir. Hipertiroidiye sekonder hiperkalsemiye azalmış ya da subnormal parathormon seviyeleri eşlik eder. Hipertiroidizm ile hiperparatiroidizm birlikteliği nadir olarak görülmektedir. Bununla birlikte, hipertiroidi hastalarında ötiroid duruma ulaştıktan sonra hiperkalseminin devam etmesi durumunda paratiroid bezlerinin ayrıntılı olarak değerlendirilmesi gerekir.

Burada, hiperkalsemisi olan, Graves hastalığı ve primer hiperparatiroidizm tanısı alan, kombine tiroid ve paratiroid cerrahisi ile başarılı bir şekilde tedavi edilen 30 yaşında bir erkek hasta olgusunu sunuyoruz.

Anahtar Kelimeler

Hipertiroidizm, hiperparatiroidizm, hiperkalsemi, Graves hastalığı

Kaynakça

• 1. Baxter JD, Bondy PK. Hypercalcemia of thyrotoxicosis. Ann Intern Med. 1966;65(3):429-42.
• 2. Chen K, Xie Y, Zhao L, Mo Z. Hyperthyroidism-associated hypercalcemic crisis: A case report and review of the literature. Medicine (Baltimore). 2017;96(4):6017.
• 3. Nicholls JJ, Brassill MJ, Williams GR, Bassett JH. The skeletal consequences of thyrotoxicosis. J. Endocrinol. 2012;213(3):209-21.
• 4. Cardoso LF, Maciel LM, Paula FJ. The multiple effects of thyroid disorders on bone and mineral metabolism. Arq Bras Endocrinol Metabol. 2014;58(5):452-63.
• 5. Dhanwal DK. Thyroid disorders and bone mineral metabolism. Indian J Endocrinol Metab. 2011;15(2):107-12.
• 6. Mosekilde L, Christensen MS. Decreased parathyroid function in hyperthyroidism: interrelationships between serum parathyroid hormone, calcium-phosphorus metabolism and thyroid function. Acta Endocrinol (Copenh). 1977;84(3):566-75.
• 7. Beus KS, Stack BC. Synchronous thyroid pathology in patients presenting with primary hyperparathyroidism. Am J Otolaryngol. 2004;25(5):308-12.
• 8. Morita SY, Somervell H, Umbricht CB, Dackiw AP, Zeiger MA. Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery. 2008;144(6):862-6.
• 9. Goldfarb M, O Neal P, Shih JL, Hartzband P, Connolly J, Hasselgren PO. Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism. Endocr Pract. 2009;15(5):463-8.
• 10. Arem R, Lim-Abrahan MA, Mallette LE. Concomitant Graves’ disease and primary hyperparathyroidism. Influence of hyperthyroidism on serum calcium and parathyroid hormone. Am J Med. 1986;80(4):693-8.
• 11. Wei S, Baloch ZW, LiVolsi VA. Parathyroid adenoma in patients with Graves' disease: a report of 21 cases. Endocr Pathol. 2015;26(1):71-4.
• 12. Abboud B, Sleilaty G, Mansour E, El Ghoul R, Tohme C, Noun R, Sarkis R. Prevalence and risk factors for primary hyperparathyroidism in hyperthyroid patients. Head Neck. 2006;28(5):420-6.
• 13. Cai X, Yousefzadeh P, Wang X. Hypercalcemia caused by concomitant Graves disease and primary hyperparathyroidism. J Endocrinol Thyroid Res. 2018;3(1):555603.
• 14. Thalhammer M, Cuk A, Pitzl H, Palitzsch KD. Concomitant Graves’ disease and primary hyperparathyroidism: clinical implications and preoperative localization of parathyroid adenoma by fine needle biopsy. CEJ Med. 2006;1(3):298-305
• 15. Miani C, Bracale AM, Bresadola V, Motz E. Concomitant primary hyperparathyroidism, Graves' disease and vitamin D deficiency. Acta Otorhinolaryngol Ital. 2003;23(3):199-202.